Skip to main content

CAR-T detection by IVFC

CAR-T detection by label-free invitro flow cytometry

All genders
person-wave 18+
Recruiting now


Principal Investigator: Andreas Klein, MD

Patients receiving commercial CAR-T therapy for their clinical care are invited to provide 5 blood draws at the time blood is drawn for their clinical care. The samples will be used to help develop a new technology for detecting CAR-T cells in the blood.

Contact Us

Andreas Klein, MD

Study details

Inclusion Criteria
  • Scheduled to receive commercial CAR-T therapy targeting CD19
Study Requirements

Study participation will consist of 5 blood draws over the course of 4 weeks, totaling 40 mL (5 Tablespoons). Medical records related to CAR-T infusion will be reviewed for 3 months.

Jump back to top